Biostatistical Considerations When Using RWD and RWE in Clinical Studies for Regulatory Purposes: A Landscape Assessment
| Autor: | Frank W. Rockhold, Richard C. Zink, Yixin Fang, JC Chen, Pallavi Mishra-Kalyani, Weili He, Martin Ho, Douglas E. Faries, Kwan Lee, Benjamin A. Goldstein, Hong-Wei Wang, Mark Levenson |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Statistics and Probability
Engineering Knowledge management business.industry Pharmaceutical Science 01 natural sciences Clinical Practice 010104 statistics & probability 03 medical and health sciences 0302 clinical medicine Medical product Landscape assessment 030212 general & internal medicine 0101 mathematics business |
| Zdroj: | Statistics in Biopharmaceutical Research. 15:3-13 |
| ISSN: | 1946-6315 |
| Popis: | Real-world evidence (RWE), derived from data from “real-world” clinical practice and medical product utilization, is an increasingly important source of evidence that holds great potential to incre... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|